Federal complaints by University of Michigan, University of Kansas Hospital Authority, and Mount Sinai entities seek recovery of approximately $250 million in alleged 340B savings diversion from ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

In part 2 of his recent interview with The American Journal of Managed Care ®, Adam Kittai, MD, addressed how he counsels ...

USPSTF recommendations have statutory coverage implications under the ACA, mandating no-cost coverage for graded preventive services and directly shaping access to mammography, colorectal screening, ...

Average Marketplace deductibles rose from $2,759 (2025) to $3,786 (2026), predominantly reflecting plan-mix changes; holding 2025 selection constant would have yielded a 6% increase. Bronze enrollment ...

Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous labeling and clinician uncertainty. Pathobiologic overlap with HFrEF supports ...

In an interview with The American Journal of Managed Care ® (AJMC ®) at the American Thoracic Society International ...

Compared with usual care, a dementia care management program improved various cost of care and utilization metrics in a Medicare managed care population at 12 months. Objectives: To examine a 12-month ...

FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...

Implementing Early Detection in CRM Syndrome,’ the expert nephrologist explored the following questions: What role do ...

Nearly one-third of patients diagnosed with vitiligo go untreated after their diagnosis, and those who did receive care cycle ...

Formal adoption of PMOS replaces a cyst-centric label with terminology capturing endocrine, metabolic, and ovarian ...